Chitinase 3-like 1 is neurotoxic in primary cultured neurons.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 04 2020
Historique:
received: 18 12 2019
accepted: 06 04 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 22 12 2020
Statut: epublish

Résumé

Chitinase 3-like 1 (CHI3L1) is known to play a role as prognostic biomarker in the early stages of multiple sclerosis (MS), and patients with high cerebrospinal fluid CHI3L1 levels have an increased risk for the development of neurological disability. Here, we investigated its potential neurotoxic effect by adding recombinant CHI3L1 in vitro to primary cultures of mouse cortical neurons and evaluating both neuronal functionality and survival by immunofluorescence. CHI3L1 induced a significant neurite length retraction after 24 and 48 hours of exposure and significantly reduced neuronal survival at 48 hours. The cytotoxic effect of CHI3L1 was neuron-specific and was not observed in mouse immune or other central nervous system cells. These results point to a selective neurotoxic effect of CHI3L1 in vitro and suggest a potential role of CHI3L1 as therapeutic target in MS patients.

Identifiants

pubmed: 32346016
doi: 10.1038/s41598-020-64093-2
pii: 10.1038/s41598-020-64093-2
pmc: PMC7188887
doi:

Substances chimiques

Biomarkers 0
Chitinase-3-Like Protein 1 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7118

Références

Comabella, M. et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 133, 1082–1093 (2010).
doi: 10.1093/brain/awq035
Canto, E. et al. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain 138, 918–931 (2015).
doi: 10.1093/brain/awv017
Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 338, 278–285 (1998).
doi: 10.1056/NEJM199801293380502
Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T. & Brück, W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123, 1174–1183 (2000).
pubmed: 10825356
Renkema, G. H. et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 251, 504–509 (1998).
doi: 10.1046/j.1432-1327.1998.2510504.x
Bonneh-Barkay, D., Wang, G., Starkey, A., Hamilton, R. L. & Wiley, C. A. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 7, 34 (2010).
doi: 10.1186/1742-2094-7-34
Huang, C. et al. Profiling the genes affected by pathogenic TDP-43 in astrocytes. J Neurochem. 129, 932–939 (2014).
doi: 10.1111/jnc.12660
Mainen, Z. F. et al. Influence of dendritic structure on firing pattern in model neocortical neurons. Nature 382, 363–366 (1996).
doi: 10.1038/382363a0
Reese, D. & Drapeau, P. Neurite growth patterns leading to functional synapses in an identified embryonic neuron. J Neurosci. 18, 5652–5662 (1998).
doi: 10.1523/JNEUROSCI.18-15-05652.1998
Pool, M., Thiemann, J., Bar-Or, A. & Fournier, A. E. Neurite Tracer: a novel ImageJ plugin for automated quantification of neurite outgrowth. J Neurosci Methods 168, 134–139 (2008).
doi: 10.1016/j.jneumeth.2007.08.029

Auteurs

Clara Matute-Blanch (C)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. clara.matute@vhir.org.

Laura Calvo-Barreiro (L)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Iria Carballo-Carbajal (I)

Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.

Ricardo Gonzalo (R)

Statistics and Bioinformatics Unit. Vall d'Hebron Institut de Recerca, Barcelona, Spain.

Alex Sanchez (A)

Statistics and Bioinformatics Unit. Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Genetics, Microbiology and Statistics Department, Universitat de Barcelona, Barcelona, Spain.

Miquel Vila (M)

Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain.
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.

Xavier Montalban (X)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Manuel Comabella (M)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. manuel.comabella@vhir.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH